Optimal adjuvant therapy in clinically N2 non-small cell...

Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio

Shinde, Ashwin, Horne, Zachary D., Li, Richard, Glaser, Scott, Massarelli, Erminia, Koczywas, Marianna, Erhunmwunsee, Loretta, Reckamp, Karen L., Weksler, Benny, Salgia, Ravi, Beriwal, Sushil, Amini,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
133
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2019.05.020
Date:
July, 2019
File:
PDF, 1.14 MB
2019
Conversion to is in progress
Conversion to is failed